Article
Thermodynamic integration combined with molecular dynamic simulations to explore the cross-resistance mechanism of isoniazid and ethionamide.
Proteins - 1 May 2022
Zhang Qianqian, Yang Yuwei, Gong Xiaoqing, Zhao Nannan, Zhang Yang, Liu Huanxiang
Abstract excerpt
Tuberculosis is an ancient disease of mankind, and its causative bacterium is Mycobacterium tuberculosis. Isoniazid is one of the most effective first-line antituberculosis drugs. As prodrugs, it and its derivative ethionamide act on enoyl-acyl carrier protein reductase (InhA) after being oxidized in bacteria, and kill the bacteria by inhibiting the formation of M. tuberculosis cell walls. However, the S94A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
